92 related articles for article (PubMed ID: 8575709)
1. [p53--a key gene for cancer development. Its central significance discloses itself to researchers step by step].
Janssen K
Fortschr Med; 1995 Dec; 113(34):48-50. PubMed ID: 8575709
[No Abstract] [Full Text] [Related]
2. Tumor suppressor genes: at the crossroads of molecular carcinogenesis, molecular epidemiology, and human risk assessment.
Harris CC
Prev Med; 1996; 25(1):10-2. PubMed ID: 8778751
[No Abstract] [Full Text] [Related]
3. [Clinical significance of p53 tumor suppressor gene mutations in adenocarcinoma in Barrett esophagus].
Schneider PM; Hölscher AH; Wegerer S; König U; Becker K; Siewert JR
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):495-9. PubMed ID: 14518305
[TBL] [Abstract][Full Text] [Related]
4. [Tumor suppressor gene p53--function and significance in gastroenterology].
Schoppmeyer K; Keim V; Mössner J
Z Gastroenterol; 1997 Jun; 35(6):491-509. PubMed ID: 9281241
[TBL] [Abstract][Full Text] [Related]
5. [Molecular biology of tobacco smoke associated neoplasia].
Zojer N; Fritsche R; Fiegl M; Schulte-Hermann R; Mannhalter C; Huber H
Wien Klin Wochenschr; 1996; 108(18):574-81. PubMed ID: 9012141
[TBL] [Abstract][Full Text] [Related]
6. Negative immunohistochemical staining of p53 protein does not always reflect wild-type p53 gene in cancer cells.
Horiuchi H; Kawamata H; Omotehara F; Fujii S; Fujimori T; Kuroda Y
J Gastroenterol; 2004 Aug; 39(8):801-3. PubMed ID: 15338377
[No Abstract] [Full Text] [Related]
7. p53 mutations in head and neck cancer: new data and evaluation of mutational spectra.
Olshan AF; Weissler MC; Pei H; Conway K
Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):499-504. PubMed ID: 9232336
[TBL] [Abstract][Full Text] [Related]
8. The etiology of human cancers.
Kleihues P
Prev Med; 1996; 25(1):13. PubMed ID: 8778752
[No Abstract] [Full Text] [Related]
9. [The p53 gene and protein in 2005: new results, promising opportunities].
Szoke D; Sipos F; Spisák S; Molnár B; Tulassay Z
Orv Hetil; 2005 Jul; 146(30):1587-94. PubMed ID: 16136736
[TBL] [Abstract][Full Text] [Related]
10. Association of p53 arginine polymorphism with skin cancer.
de Oliveira WR; Rady PL; Grady J; Hughes TK; Neto CF; Rivitti EA; Tyring SK
Int J Dermatol; 2004 Jul; 43(7):489-93. PubMed ID: 15230885
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of tumor suppressor gene p53 in head and neck tumors].
Preisler V; Kirchner S; Hagen R
HNO; 1997 Sep; 45(9):659-62. PubMed ID: 9417443
[No Abstract] [Full Text] [Related]
12. Malignant transformation of mature cystic teratoma to squamous cell carcinoma involves altered expression of p53- and p16/Rb-dependent cell cycle regulator proteins.
Iwasa A; Oda Y; Kurihara S; Ohishi Y; Yasunaga M; Nishimura I; Takagi E; Kobayashi H; Wake N; Tsuneyoshi M
Pathol Int; 2008 Dec; 58(12):757-64. PubMed ID: 19067849
[TBL] [Abstract][Full Text] [Related]
13. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic and carcinogenetic appraisal of DNA replication error in sporadic T3N0M0 stage colorectal cancer after curative resection.
Liang JT; Chang KJ; Chen JC; Lee CC; Cheng YM; Hsu HC; Chien CT; Wang SM
Hepatogastroenterology; 1999; 46(26):883-90. PubMed ID: 10370632
[TBL] [Abstract][Full Text] [Related]
15. p53 website and analysis of p53 gene mutations in human cancer: forging a link between epidemiology and carcinogenesis.
Soussi T; Dehouche K; Béroud C
Hum Mutat; 2000; 15(1):105-13. PubMed ID: 10612830
[TBL] [Abstract][Full Text] [Related]
16. The value of p53 protein expression in gallbladder carcinoma: analysis of 60 cases.
da Rocha AO; Coutinho LM; Scholl JG; Leboutte LD
Hepatogastroenterology; 2004; 51(59):1310-4. PubMed ID: 15362740
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of the p53 gene.
Sidransky D; Hollstein M
Annu Rev Med; 1996; 47():285-301. PubMed ID: 8712782
[TBL] [Abstract][Full Text] [Related]
18. [Gene therapy of malignant tumors].
Schackert HK; Frost P
Chirurg; 1993 Sep; 64(9):678-83. PubMed ID: 8222924
[No Abstract] [Full Text] [Related]
19. p53 mutation heterogeneity in cancer.
Soussi T; Lozano G
Biochem Biophys Res Commun; 2005 Jun; 331(3):834-42. PubMed ID: 15865939
[TBL] [Abstract][Full Text] [Related]
20. [Indirect detection of genetic mutations in colon cancers].
Heinzlmann M; Loeschke K; Folwaczny C
Z Gastroenterol; 1999 Feb; 37(2):195-8. PubMed ID: 10190252
[No Abstract] [Full Text] [Related]
[Next] [New Search]
